BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology. 2013;145:293-308. [PMID: 23751777 DOI: 10.1053/j.gastro.2013.05.050] [Cited by in Crossref: 179] [Cited by in F6Publishing: 175] [Article Influence: 19.9] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Wang Y, Shao S, Yu H, Wang D, Li C, Yuan Q, Liu W, Cao J, Wang X, Guo H, Wu X, Wang S. Rabdosia serra alleviates dextran sulfate sodium salt-induced colitis in mice through antiinflammation, regulating Th17/Treg balance, maintaining intestinal barrier integrity, and modulating gut microbiome. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.08.001] [Reference Citation Analysis]
2 Vieujean S, Caron B, Haghnejad V, Jouzeau JY, Netter P, Heba AC, Ndiaye NC, Moulin D, Barreto G, Danese S, Peyrin-Biroulet L. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. Int J Mol Sci 2022;23:7611. [PMID: 35886959 DOI: 10.3390/ijms23147611] [Reference Citation Analysis]
3 Wang J, Huang J, Fang L, Chen G. Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner. Computational and Mathematical Methods in Medicine 2022;2022:1-5. [DOI: 10.1155/2022/1335562] [Reference Citation Analysis]
4 Wu Z, Liu X, Huang S, Li T, Zhang X, Pang J, Zhao J, Chen L, Zhang B, Wang J, Han D. Milk Fat Globule Membrane Attenuates Acute Colitis and Secondary Liver Injury by Improving the Mucus Barrier and Regulating the Gut Microbiota. Front Immunol 2022;13:865273. [DOI: 10.3389/fimmu.2022.865273] [Reference Citation Analysis]
5 G N, Zilbauer M. Epigenetics in IBD: a conceptual framework for disease pathogenesis. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102120] [Reference Citation Analysis]
6 Wang G, Yuan J, Luo J, Ocansey DKW, Zhang X, Qian H, Xu W, Mao F. Emerging role of protein modification in inflammatory bowel disease. J Zhejiang Univ Sci B 2022;23:173-88. [PMID: 35261214 DOI: 10.1631/jzus.B2100114] [Reference Citation Analysis]
7 Noble AJ, Purcell RV, Adams AT, Lam YK, Ring PM, Anderson JR, Osborne AJ. A Final Frontier in Environment-Genome Interactions? Integrated, Multi-Omic Approaches to Predictions of Non-Communicable Disease Risk. Front Genet 2022;13:831866. [PMID: 35211161 DOI: 10.3389/fgene.2022.831866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao SB, Wu JY, He ZX, Song YH, Chang X, Xia T, Fang X, Li ZS, Xu C, Wang SL, Bai Y. Corticotropin releasing hormone promotes inflammatory bowel disease via inducing intestinal macrophage autophagy. Cell Death Discov 2021;7:377. [PMID: 34873177 DOI: 10.1038/s41420-021-00767-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wang JM, Lin SR, Zhu YB, Yuan J, Wang YM, Zhang Q, Xie LS, Li SH, Liu SQ, Yu SG, Wu QF. Proteomic analysis of lysine acetylation reveals that metabolic enzymes and heat shock proteins may be potential targets for DSS-induced mice colitis. Int Immunopharmacol 2021;101:108336. [PMID: 34768127 DOI: 10.1016/j.intimp.2021.108336] [Reference Citation Analysis]
10 Niu W, Dong Y, Fu Z, Lv J, Wang L, Zhang Z, Huo J, Ju J. Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model. Int J Biol Macromol 2021:S0141-8130(21)02422-3. [PMID: 34748786 DOI: 10.1016/j.ijbiomac.2021.11.024] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
11 Wang Z, Huang Y, Wang D, Wang R, Li K, Qi Q, Ma Z, Gu M, Zheng H, Lu Y, Wu L. Genome-Wide Regulation of Acupuncture and Moxibustion on Ulcerative Colitis Rats. Evid Based Complement Alternat Med 2021;2021:9945121. [PMID: 34659440 DOI: 10.1155/2021/9945121] [Reference Citation Analysis]
12 Li B, Li Y, Li L, Yu Y, Gu X, Liu C, Long X, Yu Y, Zuo X. Hsa_circ_0001021 regulates intestinal epithelial barrier function via sponging miR-224-5p in ulcerative colitis. Epigenomics 2021;13:1385-401. [PMID: 34528447 DOI: 10.2217/epi-2021-0230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ronchetti S, Gentili M, Ricci E, Migliorati G, Riccardi C. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:1017-25. [PMID: 31961437 DOI: 10.1093/ibd/izz331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
14 Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, Zhang G, Zhao J, Wang J. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome 2021;9:184. [PMID: 34493333 DOI: 10.1186/s40168-021-01115-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 47] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li C, Chen Y, Zhu H, Zhang X, Han L, Zhao Z, Wang J, Ning L, Zhou W, Lu C, Xu L, Sang J, Feng Z, Zhang Y, Lou X, Bo X, Zhu B, Yu C, Zheng M, Li Y, Sun J, Shen Z. Inhibition of Histone Deacetylation by MS-275 Alleviates Colitis by Activating the Vitamin D Receptor. J Crohns Colitis 2020;14:1103-18. [PMID: 32030401 DOI: 10.1093/ecco-jcc/jjaa016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
16 Lee JW, Lee SM, Chun J, Im JP, Seo SK, Ha N, Il Choi Y, Kim JS. Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-κB Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis. Inflamm Bowel Dis 2020;26:852-62. [PMID: 31895948 DOI: 10.1093/ibd/izz317] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
17 Selmin OI, Papoutsis AJ, Hazan S, Smith C, Greenfield N, Donovan MG, Wren SN, Doetschman TC, Snider JM, Snider AJ, Chow SH, Romagnolo DF. n-6 High Fat Diet Induces Gut Microbiome Dysbiosis and Colonic Inflammation. Int J Mol Sci 2021;22:6919. [PMID: 34203196 DOI: 10.3390/ijms22136919] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
18 Gong L, Xiao J, Yi J, Xiao J, Lu F, Liu X. Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macrophages via Let-7b-5p/TLR4 Signaling. Inflamm Bowel Dis 2021:izab132. [PMID: 34106260 DOI: 10.1093/ibd/izab132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen Y, Liu M, Wang W, Cai W, Song W, Li L, Lin GN. Loss of Setd2 associates with aberrant microRNA expression and contributes to inflammatory bowel disease progression in mice. Genomics 2021;113:2441-54. [PMID: 34052319 DOI: 10.1016/j.ygeno.2021.05.034] [Reference Citation Analysis]
20 Zhang XZ, Luo DX, Bai XH, Ding HH, Liu M, Deng J, Mai JW, Yang YL, Zhang SB, Ruan XC, Zhang XQ, Xin WJ, Xu T. Upregulation of TRPC6 Mediated by PAX6 Hypomethylation Is Involved in the Mechanical Allodynia Induced by Chemotherapeutics in Dorsal Root Ganglion. Int J Neuropsychopharmacol 2020;23:257-67. [PMID: 32124922 DOI: 10.1093/ijnp/pyaa014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Enderle K, Dinkel M, Spath EM, Schmid B, Zundler S, Tripal P, Neurath MF, Hildner K, Neufert C. Dynamic Imaging of IEL-IEC Co-Cultures Allows for Quantification of CD103-Dependent T Cell Migration. Int J Mol Sci 2021;22:5148. [PMID: 34067987 DOI: 10.3390/ijms22105148] [Reference Citation Analysis]
22 Hornschuh M, Wirthgen E, Wolfien M, Singh KP, Wolkenhauer O, Däbritz J. The role of epigenetic modifications for the pathogenesis of Crohn's disease. Clin Epigenetics 2021;13:108. [PMID: 33980294 DOI: 10.1186/s13148-021-01089-3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 Li Y, Wang Z, Wu X, Wang G, Gu G, Ren H, Hong Z, Ren J. Intestinal mucosa-derived DNA methylation signatures in the penetrating intestinal mucosal lesions of Crohn's disease. Sci Rep 2021;11:9771. [PMID: 33963246 DOI: 10.1038/s41598-021-89087-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 He JS, Tan JY, Li XZ, Feng R, Xiong SS, Lin SN, Qiu Y, Mao R. Serum biomarkers of fibrostenotic Crohn's disease: Where are we now? J Dig Dis 2020;21:336-41. [PMID: 32496631 DOI: 10.1111/1751-2980.12913] [Reference Citation Analysis]
25 Tauc HM, Rodriguez-Fernandez IA, Hackney JA, Pawlak M, Ronnen Oron T, Korzelius J, Moussa HF, Chaudhuri S, Modrusan Z, Edgar BA, Jasper H. Age-related changes in polycomb gene regulation disrupt lineage fidelity in intestinal stem cells. Elife 2021;10:e62250. [PMID: 33724181 DOI: 10.7554/eLife.62250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Giudici F, Cavalli T, Luceri C, Russo E, Zambonin D, Scaringi S, Ficari F, Fazi M, Amedei A, Tonelli F, Malentacchi C. Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients. Mediators Inflamm 2021;2021:8854916. [PMID: 33708009 DOI: 10.1155/2021/8854916] [Reference Citation Analysis]
27 Sun Y, Baptista LC, Roberts LM, Jumbo-Lucioni P, McMahon LL, Buford TW, Carter CS. The Gut Microbiome as a Therapeutic Target for Cognitive Impairment. J Gerontol A Biol Sci Med Sci 2020;75:1242-50. [PMID: 31811292 DOI: 10.1093/gerona/glz281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
28 Alemany-Cosme E, Sáez-González E, Moret I, Mateos B, Iborra M, Nos P, Sandoval J, Beltrán B. Oxidative Stress in the Pathogenesis of Crohn's Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics. Antioxidants (Basel) 2021;10:64. [PMID: 33430227 DOI: 10.3390/antiox10010064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
29 Jiang X, Xing L, Chen Y, Qin R, Song S, Lu Y, Xie S, Wang L, Pu H, Gui X, Li T, Xu J, Li J, Jia S, Lu D. CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells. Mol Ther Nucleic Acids 2021;23:310-23. [PMID: 33425489 DOI: 10.1016/j.omtn.2020.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
30 Ma Y, Hu C, Yan W, Jiang H, Liu G. Lactobacillus pentosus Increases the Abundance of Akkermansia and Affects the Serum Metabolome to Alleviate DSS-Induced Colitis in a Murine Model. Front Cell Dev Biol 2020;8:591408. [PMID: 33195257 DOI: 10.3389/fcell.2020.591408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Moret-Tatay I, Cerrillo E, Sáez-González E, Hervás D, Iborra M, Sandoval J, Busó E, Tortosa L, Nos P, Beltrán B. Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease. Clin Transl Gastroenterol 2019;10:e00083. [PMID: 31663908 DOI: 10.14309/ctg.0000000000000083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
32 Gimier E, Chervy M, Agus A, Sivignon A, Billard E, Privat M, Viala S, Minet-Quinard R, Buisson A, Vazeille E, Barnich N, Denizot J. Methyl-donor supplementation prevents intestinal colonization by Adherent-Invasive E. coli in a mouse model of Crohn's disease. Sci Rep 2020;10:12922. [PMID: 32737335 DOI: 10.1038/s41598-020-69472-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Malesza IJ, Malesza M, Krela-Kaźmierczak I, Zielińska A, Souto EB, Dobrowolska A, Eder P. Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults. Int J Mol Sci 2020;21:E5223. [PMID: 32718006 DOI: 10.3390/ijms21155223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
34 Kalla R, Adams AT, Ventham NT, Kennedy NA, White R, Clarke C, Ivens A, Bergemalm D, Vatn S, Lopez-Jimena B, Ricanek P, Vatn MH, Söderholm J, Gomollón F, Nowak JK, Jahnsen J, Halfvarson J, McTaggart S, Ho GT, Buck A, Satsangi J; IBD Character Consortium. Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease. J Crohns Colitis 2020:jjaa134. [PMID: 32598439 DOI: 10.1093/ecco-jcc/jjaa134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
35 Annese V. Genetics and epigenetics of IBD. Pharmacol Res 2020;159:104892. [PMID: 32464322 DOI: 10.1016/j.phrs.2020.104892] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
36 Fiocchi C, Iliopoulos D. What's new in IBD therapy: An "omics network" approach. Pharmacol Res 2020;159:104886. [PMID: 32428668 DOI: 10.1016/j.phrs.2020.104886] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
37 Li X, Yang G, Wu L, Hong J, Zhao Y, Liu J, Kong X, Dong X, Zhi F, Ma X, Yang L, Zhang D. Regulatory effects of moxibustion on ubiquitin and NLRP3 proteins in colon of ulcerative colitis rats. J Acupunct Tuina Sci 2020;18:96-104. [DOI: 10.1007/s11726-020-1162-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Eissa N, Mujawar Q, Alabdoulsalam T, Zohni S, El-Matary W. The immune-sleep crosstalk in inflammatory bowel disease. Sleep Med 2020;73:38-46. [PMID: 32769031 DOI: 10.1016/j.sleep.2020.04.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Res 2020;9:F1000 Faculty Rev-294. [PMID: 32399194 DOI: 10.12688/f1000research.20805.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
40 Muller M, Hansmannel F, Arnone D, Choukour M, Ndiaye NC, Kokten T, Houlgatte R, Peyrin-Biroulet L. Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer. United European Gastroenterol J 2020;8:675-84. [PMID: 32268844 DOI: 10.1177/2050640620919254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
41 Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients 2020;12:E944. [PMID: 32235316 DOI: 10.3390/nu12040944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 73] [Article Influence: 16.0] [Reference Citation Analysis]
42 Chen M, Li Q, Cao N, Deng Y, Li L, Zhao Q, Wu M, Ye M. Profiling of histone 3 lysine 27 acetylation reveals its role in a chronic DSS-induced colitis mouse model. Mol Omics 2019;15:296-307. [PMID: 31147658 DOI: 10.1039/c9mo00070d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
43 Hooper KM, Barlow PG, Henderson P, Stevens C. Interactions Between Autophagy and the Unfolded Protein Response: Implications for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019;25:661-671. [PMID: 30590697 DOI: 10.1093/ibd/izy380] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
44 Jones GR, Brown SL, Phythian-Adams AT, Ivens AC, Cook PC, MacDonald AS. The Methyl-CpG-Binding Protein Mbd2 Regulates Susceptibility to Experimental Colitis via Control of CD11c+ Cells and Colonic Epithelium. Front Immunol 2020;11:183. [PMID: 32117307 DOI: 10.3389/fimmu.2020.00183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
45 Arafa EA, Mohamed WR, Zaher DM, Omar HA. Gliclazide attenuates acetic acid-induced colitis via the modulation of PPARγ, NF-κB and MAPK signaling pathways. Toxicol Appl Pharmacol 2020;391:114919. [PMID: 32045587 DOI: 10.1016/j.taap.2020.114919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Zhu M, Xie J. LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL. Dig Dis Sci 2020;65:3191-6. [DOI: 10.1007/s10620-020-06093-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
47 Cao F, Liu J, Sha B, Pan H. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy. CPD 2020;25:4893-913. [DOI: 10.2174/1381612825666191216154224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
48 Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019;94:1357-1373. [PMID: 31272578 DOI: 10.1016/j.mayocp.2019.01.018] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 27.0] [Reference Citation Analysis]
49 Yang YX, Shen HH, Cao F, Xie LY, Zhu GL, Sam NB, Wang DG, Pan HF. Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases. Expert Opin Ther Targets 2019;23:1015-30. [PMID: 31747802 DOI: 10.1080/14728222.2019.1696309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
50 Kalla R, Adams AT, Satsangi J. Blood-based DNA methylation in Crohn's disease and severity of intestinal inflammation. Transl Gastroenterol Hepatol 2019;4:76. [PMID: 31872140 DOI: 10.21037/tgh.2019.10.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Zhou YJ, Zhao BL, Qian Z, Xu Y, Ding YQ. Association of Glutathione S-Transferase M1 null genotype with inflammatory bowel diseases: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e17722. [PMID: 31689810 DOI: 10.1097/MD.0000000000017722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. [PMID: 31737035 DOI: 10.3389/fgene.2019.01017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
53 Dotti I, Salas A. Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2018;24:2501-2509. [PMID: 30169820 DOI: 10.1093/ibd/izy275] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
54 Mitchell J, Kim SJ, Koukos G, Seelmann A, Veit B, Shepard B, Blumer-Schuette S, Winter HS, Iliopoulos D, Pothoulakis C, Im E, Rhee SH. Colonic Inhibition of Phosphatase and Tensin Homolog Increases Colitogenic Bacteria, Causing Development of Colitis in Il10-/- Mice. Inflamm Bowel Dis 2018;24:1718-32. [PMID: 29788382 DOI: 10.1093/ibd/izy124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
55 He J, Song Y, Li G, Xiao P, Liu Y, Xue Y, Cao Q, Tu X, Pan T, Jiang Z, Cao X, Lai L, Wang Q. Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation. J Clin Invest 2019;129:3877-93. [PMID: 31246581 DOI: 10.1172/JCI123374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
56 Gao C, Liu L, Zhou Y, Bian Z, Wang S, Wang Y. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin Med 2019;14:23. [PMID: 31236131 DOI: 10.1186/s13020-019-0245-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
57 Zhou Q, Zhang Y, Wang B, Zhou W, Bi Y, Huai W, Chen X, Chen Y, Liu Z, Liu X, Zhan Z. KDM2B promotes IL-6 production and inflammatory responses through Brg1-mediated chromatin remodeling. Cell Mol Immunol 2020;17:834-42. [PMID: 31197256 DOI: 10.1038/s41423-019-0251-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
58 Zhou J, Huang S, Wang Z, Huang J, Xu L, Tang X, Wan YY, Li QJ, Symonds ALJ, Long H, Zhu B. Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation. Nat Commun 2019;10:2427. [PMID: 31160593 DOI: 10.1038/s41467-019-10176-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
59 Argollo M, Gilardi D, Roda G, Fiorino G, Peyrin-biroulet L, Danese S. Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time? CPD 2019;25:47-56. [DOI: 10.2174/1381612825666190308100844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
60 Sáez-González E, Mateos B, López-Muñoz P, Iborra M, Moret I, Nos P, Beltrán B. Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.Nutrients. 2019;11:1062. [PMID: 31083616 DOI: 10.3390/nu11051062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
61 Meddens CA, van der List ACJ, Nieuwenhuis EES, Mokry M. Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potential. Gut 2019;68:928-41. [PMID: 30692146 DOI: 10.1136/gutjnl-2018-317516] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
62 Wang T, Chen N, Ren W, Liu F, Gao F, Ye L, Han Y, Zhang Y, Liu Y. Integrated analysis of circRNAs and mRNAs expression profile revealed the involvement of hsa_circ_0007919 in the pathogenesis of ulcerative colitis. J Gastroenterol 2019;54:804-18. [PMID: 31037450 DOI: 10.1007/s00535-019-01585-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
63 Reinoso Webb C, den Bakker H, Koboziev I, Jones-Hall Y, Rao Kottapalli K, Ostanin D, Furr KL, Mu Q, Luo XM, Grisham MB. Differential Susceptibility to T Cell-Induced Colitis in Mice: Role of the Intestinal Microbiota. Inflamm Bowel Dis 2018;24:361-79. [PMID: 29361089 DOI: 10.1093/ibd/izx014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 12.7] [Reference Citation Analysis]
64 Zeng B, Shi S, Ashworth G, Dong C, Liu J, Xing F. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis 2019;10:315. [PMID: 30962426 DOI: 10.1038/s41419-019-1540-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 80] [Article Influence: 17.7] [Reference Citation Analysis]
65 Schulte L, Hohwieler M, Müller M, Klaus J. Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease. Stem Cells Int 2019;2019:8010645. [PMID: 31015842 DOI: 10.1155/2019/8010645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Yu Y, Chen KC, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis. World J Pediatr. 2019;15:26-36. [PMID: 30666565 DOI: 10.1007/s12519-018-0204-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
67 Reddavide R, Rotolo O, Caruso MG, Stasi E, Notarnicola M, Miraglia C, Nouvenne A, Meschi T, De' Angelis GL, Di Mario F, Leandro G. The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. Acta Biomed 2018;89:60-75. [PMID: 30561397 DOI: 10.23750/abm.v89i9-S.7952] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
68 Tang WJ, Peng KY, Tang ZF, Wang YH, Xue AJ, Huang Y. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease. World J Gastroenterol 2018; 24(46): 5234-5245 [PMID: 30581272 DOI: 10.3748/wjg.v24.i46.5234] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
69 Baker KT, Salk JJ, Brentnall TA, Risques RA. Precancer in ulcerative colitis: the role of the field effect and its clinical implications. Carcinogenesis 2018;39:11-20. [PMID: 29087436 DOI: 10.1093/carcin/bgx117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
70 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
71 Li Z, Wang Y, Zhu Y. Association of miRNA-146a rs2910164 and miRNA-196 rs11614913 polymorphisms in patients with ulcerative colitis: A meta-analysis and review. Medicine (Baltimore) 2018;97:e12294. [PMID: 30278502 DOI: 10.1097/MD.0000000000012294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Judit Béres N, Kiss Z, Müller KE, Cseh Á, Veres-Székely A, Lippai R, Benkő R, Bartha Á, Heininger S, Vannay Á, Sziksz E, Veres G, Horváth EM. Role of microRNA-223 in the regulation of poly(ADP-ribose) polymerase in pediatric patients with Crohn's disease. Scand J Gastroenterol 2018;53:1066-73. [PMID: 30299179 DOI: 10.1080/00365521.2018.1498915] [Reference Citation Analysis]
73 Oltulu P, Oltulu R, Asil M, Satirtav G, Mirza E. Conjunctival Impression Cytology and Dry Eye in Patients With Ulcerative Colitis: A Pilot Study. Eye & Contact Lens: Science & Clinical Practice 2018;44:S190-3. [DOI: 10.1097/icl.0000000000000380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Song C, Yang J, Ye W, Zhang Y, Tang C, Li X, Zhou X, Xie Y. Urban–rural environmental exposure during childhood and subsequent risk of inflammatory bowel disease: a meta-analysis. Expert Review of Gastroenterology & Hepatology 2019;13:591-602. [DOI: 10.1080/17474124.2018.1511425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Feki S, Bouzid D, Abida O, Chtourou L, Elloumi N, Toumi A, Hachicha H, Amouri A, Tahri N, Masmoudi H. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease. J Dig Dis. 2017;18:625-633. [PMID: 29055077 DOI: 10.1111/1751-2980.12552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
76 Hu Z, Yang M, Ye Q, Qin K, Wu M, Gu R, Zhou Y. Tou Nong San Attenuates Inflammation in TNBS-IBD Model by Inhibiting NF-κB Signaling Pathway. Evid Based Complement Alternat Med 2018;2018:6929307. [PMID: 30046345 DOI: 10.1155/2018/6929307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
77 Klasić M, Markulin D, Vojta A, Samaržija I, Biruš I, Dobrinić P, Ventham NT, Trbojević-Akmačić I, Šimurina M, Štambuk J, Razdorov G, Kennedy NA, Satsangi J, Dias AM, Pinho S, Annese V, Latiano A, D'Inca R, Lauc G, Zoldoš V; IBD consortium. Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease. Clin Epigenetics 2018;10:75. [PMID: 29991969 DOI: 10.1186/s13148-018-0507-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
78 Wu LY, Ma XP, Shi Y, Bao CH, Jin XM, Lu Y, Zhao JM, Zhou CL, Chen D, Liu HR. Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease. J Gastroenterol Hepatol 2017;32:1706-15. [PMID: 28261881 DOI: 10.1111/jgh.13778] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
79 Fricker M, Goggins BJ, Mateer S, Jones B, Kim RY, Gellatly SL, Jarnicki AG, Powell N, Oliver BG, Radford-Smith G, Talley NJ, Walker MM, Keely S, Hansbro PM. Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction. JCI Insight 2018;3:94040. [PMID: 29415878 DOI: 10.1172/jci.insight.94040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
80 Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN. pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis 2016;22:1908-14. [PMID: 27135480 DOI: 10.1097/MIB.0000000000000784] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
81 Becker E, Bengs S, Aluri S, Opitz L, Atrott K, Rost F, Leonardi I, Stanzel C, Raselli T, Kasper S, Ruiz P, Rogler G. Large-Scale Integrative Analysis of Epigenetic Modifications Induced by Isotretinoin, Doxycycline and Metronidazole in Murine Colonic Intestinal Epithelial Cells. Epigenomes 2017;1:24. [DOI: 10.3390/epigenomes1030024] [Reference Citation Analysis]
82 Kumar A, Malhotra P, Coffing H, Priyamvada S, Anbazhagan AN, Krishnan HR, Gill RK, Alrefai WA, Gavin DP, Pandey SC, Dudeja PK, Saksena S. Epigenetic modulation of intestinal Na+/H+ exchanger-3 expression. Am J Physiol Gastrointest Liver Physiol 2018;314:G309-18. [PMID: 29167115 DOI: 10.1152/ajpgi.00293.2017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
83 Yang J, Tan H, Gu L, Song M, Wu Y, Peng J, Lan Z, Wei Y, Hu T. Sophora subprosrate polysaccharide inhibited cytokine/chemokine secretion via suppression of histone acetylation modification and NF-κb activation in PCV2 infected swine alveolar macrophage. International Journal of Biological Macromolecules 2017;104:900-8. [DOI: 10.1016/j.ijbiomac.2017.06.102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
84 Palmieri O, Mazza T, Castellana S, Panza A, Latiano T, Corritore G, Andriulli A, Latiano A. Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier. OMICS 2016;20:692-8. [PMID: 27930092 DOI: 10.1089/omi.2016.0147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
85 Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. The Lancet Child & Adolescent Health 2017;1:147-58. [DOI: 10.1016/s2352-4642(17)30017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
86 Ley D, Desseyn JL, Mischke M, Knol J, Turck D, Gottrand F. Early-life origin of intestinal inflammatory disorders. Nutr Rev 2017;75:175-87. [PMID: 28340001 DOI: 10.1093/nutrit/nuw061] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
87 Aleksandrova K, Romero-Mosquera B, Hernandez V. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients 2017;9:E962. [PMID: 28867793 DOI: 10.3390/nu9090962] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 16.6] [Reference Citation Analysis]
88 de Souza HSP, Fiocchi C, Iliopoulos D. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14:739-749. [PMID: 28831186 DOI: 10.1038/nrgastro.2017.110] [Cited by in Crossref: 199] [Cited by in F6Publishing: 180] [Article Influence: 39.8] [Reference Citation Analysis]
89 Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Front Immunol 2017;8:942. [PMID: 28855901 DOI: 10.3389/fimmu.2017.00942] [Cited by in Crossref: 105] [Cited by in F6Publishing: 149] [Article Influence: 21.0] [Reference Citation Analysis]
90 Castro-Santos P, Moro-García MA, Marcos-Fernández R, Alonso-Arias R, Díaz-Peña R. ERAP1 and HLA-C interaction in inflammatory bowel disease in the Spanish population. Innate Immun 2017;23:476-81. [PMID: 28651467 DOI: 10.1177/1753425917716527] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
91 Schultze JL. Macrophage tolerance in the gut: It is in the epigenome! Eur J Immunol 2016;46:1838-41. [PMID: 27518699 DOI: 10.1002/eji.201646545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
92 Feuerstein JD, Cheifetz AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clin Proc. 2017;92:1088-1103. [PMID: 28601423 DOI: 10.1016/j.mayocp.2017.04.010] [Cited by in Crossref: 111] [Cited by in F6Publishing: 136] [Article Influence: 22.2] [Reference Citation Analysis]
93 Jin X, Xu H, Wu X, Li T, Li J, Zhou Y, Dan H, Jiang L, Zeng X, Ji P, Chen Q. KDM4A as a prognostic marker of oral squamous cell carcinoma: Evidence from tissue microarray studies in a multicenter cohort. Oncotarget 2017;8:80348-57. [PMID: 29113308 DOI: 10.18632/oncotarget.18302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
94 Hodjat M, Rahmani S, Khan F, Niaz K, Navaei–nigjeh M, Mohammadi Nejad S, Abdollahi M. Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view. Arch Toxicol 2017;91:2577-97. [DOI: 10.1007/s00204-017-1979-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
95 Yau YY, Leong RWL, Pudipeddi A, Redmond D, Wasinger VC. Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease. Mol Cell Proteomics. 2017;16:1244-1257. [PMID: 28490445 DOI: 10.1074/mcp.m116.066506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
96 He C, Yu T, Shi Y, Ma C, Yang W, Fang L, Sun M, Wu W, Xiao F, Guo F, Chen M, Yang H, Qian J, Cong Y, Liu Z. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. Gastroenterology 2017;152:1434-1448.e15. [DOI: 10.1053/j.gastro.2017.01.049] [Cited by in Crossref: 60] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
97 Kellermayer R. Challenges for epigenetic research in inflammatory bowel diseases. Epigenomics 2017;9:527-38. [PMID: 28343422 DOI: 10.2217/epi-2016-0155] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
98 Gabbani T, Deiana S, Marocchi M, Annese V. Genetic risk variants as therapeutic targets for Crohn's disease. Expert Opin Ther Targets 2017;21:381-90. [PMID: 28281904 DOI: 10.1080/14728222.2017.1296431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Schultz BM, Paduro CA, Salazar GA, Salazar-Echegarai FJ, Sebastián VP, Riedel CA, Kalergis AM, Alvarez-Lobos M, Bueno SM. A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases. Front Immunol 2017;8:191. [PMID: 28293241 DOI: 10.3389/fimmu.2017.00191] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
100 Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 2017;8:238-252. [PMID: 28609251 DOI: 10.1080/19490976.2017.1290757] [Cited by in Crossref: 135] [Cited by in F6Publishing: 130] [Article Influence: 27.0] [Reference Citation Analysis]
101 Huang Y, Ma Z, Cui YH, Dong HS, Zhao JM, Dou CZ, Liu HR, Li J, Wu HG. Effects of Herb-Partitioned Moxibustion on the miRNA Expression Profiles in Colon from Rats with DSS-Induced Ulcerative Colitis. Evid Based Complement Alternat Med 2017;2017:1767301. [PMID: 28246536 DOI: 10.1155/2017/1767301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
102 Zilbauer M, Zellos A, Heuschkel R, Gasparetto M, Kraiczy J, Postberg J, Greco L, Auricchio R, Galatola M, Embleton N, Wirth S, Jenke A. Epigenetics in Paediatric Gastroenterology, Hepatology, and Nutrition: Present Trends and Future Perspectives. J Pediatr Gastroenterol Nutr 2016;62:521-9. [PMID: 26628441 DOI: 10.1097/MPG.0000000000001053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
103 Cao SS. Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2016;22:984-993. [PMID: 26950312 DOI: 10.1097/mib.0000000000000660] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 8.7] [Reference Citation Analysis]
104 Wu F, Huang Y, Dong F, Kwon JH. Ulcerative Colitis-Associated Long Noncoding RNA, BC012900, Regulates Intestinal Epithelial Cell Apoptosis. Inflamm Bowel Dis. 2016;22:782-795. [PMID: 26937624 DOI: 10.1097/MIB.0000000000000691] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
105 Ventham NT, Kennedy NA, Adams AT, Kalla R, Heath S, O'Leary KR, Drummond H, Wilson DC, Gut IG, Nimmo ER, Satsangi J; IBD BIOM consortium., IBD CHARACTER consortium. Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease. Nat Commun 2016;7:13507. [PMID: 27886173 DOI: 10.1038/ncomms13507] [Cited by in Crossref: 107] [Cited by in F6Publishing: 105] [Article Influence: 17.8] [Reference Citation Analysis]
106 Fofanova TY, Petrosino JF, Kellermayer R. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;62:208-19. [PMID: 26308318 DOI: 10.1097/MPG.0000000000000950] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
107 Putignani L, Del Chierico F, Vernocchi P, Cicala M, Cucchiara S, Dallapiccola B; Dysbiotrack Study Group. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition. Inflamm Bowel Dis 2016;22:487-504. [PMID: 26588090 DOI: 10.1097/MIB.0000000000000602] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 11.7] [Reference Citation Analysis]
108 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
109 Kaplan GG, Ng SC. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology. 2017;152:313-321.e2. [PMID: 27793607 DOI: 10.1053/j.gastro.2016.10.020] [Cited by in Crossref: 375] [Cited by in F6Publishing: 433] [Article Influence: 62.5] [Reference Citation Analysis]
110 Li X, Song P, Timofeeva M, Meng X, Rudan I, Little J, Satsangi J, Campbell H, Theodoratou E. Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease. Sci Rep 2016;6:34076. [PMID: 27670835 DOI: 10.1038/srep34076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
111 Boyapati RK, Kalla R, Satsangi J, Ho GT. Biomarkers in Search of Precision Medicine in IBD. Am J Gastroenterol. 2016;111:1682-1690. [PMID: 27670602 DOI: 10.1038/ajg.2016.441] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
112 Vargas-Martínez F, Schanler RJ, Abrams SA, Hawthorne KM, Landers S, Guzman-Bárcenas J, Muñoz O, Henriksen T, Petersson M, Uvnäs-Moberg K, Jiménez-Estrada I. Oxytocin, a main breastfeeding hormone, prevents hypertension acquired in utero: A therapeutics preview. Biochim Biophys Acta Gen Subj 2017;1861:3071-84. [PMID: 27658996 DOI: 10.1016/j.bbagen.2016.09.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
113 Guo Z, Gong J, Li Y, Gu L, Cao L, Wang Z, Zhu W, Li J. Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn's Disease. Nutrients 2016;8:E519. [PMID: 27556489 DOI: 10.3390/nu8080519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
114 Kang K, Bae JH, Han K, Kim ES, Kim TO, Yi JM. A Genome-Wide Methylation Approach Identifies a New Hypermethylated Gene Panel in Ulcerative Colitis. Int J Mol Sci. 2016;17:pii E1291. [PMID: 27517910 DOI: 10.3390/ijms17081291] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
115 van der Zee HH, Horvath B, Jemec GBE, Prens EP. The Association between Hidradenitis Suppurativa and Crohn's Disease: in Search of the Missing Pathogenic Link. J Invest Dermatol 2016;136:1747-8. [PMID: 27542293 DOI: 10.1016/j.jid.2016.05.102] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
116 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
117 Li C, Kuemmerle JF. Genetic and epigenetic regulation of intestinal fibrosis. United European Gastroenterol J 2016;4:496-505. [PMID: 27536359 DOI: 10.1177/2050640616659023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
118 Cleynen I, Vermeire S. The genetic architecture of inflammatory bowel disease: Past, present and future. Curr Opin Gastroenterol. 2015;31:456-463. [PMID: 26444824 DOI: 10.1097/mog.0000000000000215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
119 Lee SJ, Lee YJ, Park KK. The pathogenesis of drug-induced liver injury. Expert Rev Gastroenterol Hepatol 2016;10:1175-85. [PMID: 27248313 DOI: 10.1080/17474124.2016.1196133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
120 Gabbani T, Deiana S, Annese AL, Lunardi S, Annese V. The genetic burden of inflammatory bowel diseases: implications for the clinic? Expert Rev Gastroenterol Hepatol 2016;10:1109-17. [PMID: 27258545 DOI: 10.1080/17474124.2016.1196131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
121 Tolentino YFM, Elia PP, Fogaça HS, Carneiro AJV, Zaltman C, Moura-neto R, Luiz RR, Carvalho MDGC, de Souza HS. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn’s Disease Phenotypes in Southeastern Brazilians. Dig Dis Sci 2016;61:2636-47. [DOI: 10.1007/s10620-016-4172-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
122 Gould NJ, Davidson KL, Nwokolo CU, Arasaradnam RP. A systematic review of the role of DNA methylation on inflammatory genes in ulcerative colitis. Epigenomics. 2016;8:667-684. [PMID: 27096966 DOI: 10.2217/epi-2016-0006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
123 Oshima T, Miwa H. Gastrointestinal mucosal barrier function and diseases. J Gastroenterol 2016;51:768-78. [PMID: 27048502 DOI: 10.1007/s00535-016-1207-z] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 20.5] [Reference Citation Analysis]
124 Sadler T, Bhasin JM, Xu Y, Barnholz-Sloan J, Chen Y, Ting AH, Stylianou E. Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis. Clin Epigenetics 2016;8:30. [PMID: 26973718 DOI: 10.1186/s13148-016-0193-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
125 Koboziev I, Jones-Hall Y, Valentine JF, Webb CR, Furr KL, Grisham MB. Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases. Inflamm Bowel Dis 2015;21:1652-73. [PMID: 26035036 DOI: 10.1097/MIB.0000000000000446] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
126 Rieder F, Latella G, Magro F, Yuksel ES, Higgins PDR, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. ECCOJC 2016;10:873-85. [DOI: 10.1093/ecco-jcc/jjw055] [Cited by in Crossref: 102] [Cited by in F6Publishing: 121] [Article Influence: 17.0] [Reference Citation Analysis]
127 Harris RA, Shah R, Hollister EB, Tronstad RR, Hovdenak N, Szigeti R, Versalovic J, Kellermayer R. Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents. J Immunol Res. 2016;2016:9170162. [PMID: 27006956 DOI: 10.1155/2016/9170162] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
128 Reinoso Webb C, Koboziev I, Furr KL, Grisham MB. Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology. 2016;23:67-80. [PMID: 26947707 DOI: 10.1016/j.pathophys.2016.02.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
129 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016; 7(1): 112-125 [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
130 Yu Q, Zhang S, Chao K, Feng R, Wang H, Li M, Chen B, He Y, Zeng Z, Chen M. E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10:713-725. [PMID: 26818663 DOI: 10.1093/ecco-jcc/jjw023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
131 Bai AH, Wu WK, Xu L, Wong SH, Go MY, Chan AW, Harbord M, Zhang S, Chen M, Wu JC. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10. J Crohns Colitis. 2016;10:726-734. [PMID: 26802082 DOI: 10.1093/ecco-jcc/jjw020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
132 Satsangi J, Kitten O, Chavez M, Kalla R, Prel N, Meuwis MA, Scott S, Bonetti I, Ventham NT, Louis E. How to Apply for and Secure EU Funding for Collaborative IBD Research Projects. J Crohns Colitis 2016;10:363-70. [PMID: 26744440 DOI: 10.1093/ecco-jcc/jjv237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
133 Díaz-Peña R, Vidal-Castiñeira JR, Moro-García MA, Alonso-Arias R, Castro-Santos P. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease. Hum Immunol 2016;77:104-9. [PMID: 26542067 DOI: 10.1016/j.humimm.2015.10.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
134 Loddo I, Romano C. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis. Front Immunol. 2015;6:551. [PMID: 26579126 DOI: 10.3389/fimmu.2015.00551] [Cited by in Crossref: 166] [Cited by in F6Publishing: 169] [Article Influence: 23.7] [Reference Citation Analysis]
135 Torres J, Colombel JF. Genetics and phenotypes in inflammatory bowel disease. Lancet. 2016;387:98-100. [PMID: 26490194 DOI: 10.1016/s0140-6736(15)00464-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
136 Serban DE. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet? Nutr Clin Pract 2015;30:760-79. [DOI: 10.1177/0884533615606898] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
137 McDermott E, Ryan EJ, Tosetto M, Gibson D, Burrage J, Keegan D, Byrne K, Crowe E, Sexton G, Malone K, Harris RA, Kellermayer R, Mill J, Cullen G, Doherty GA, Mulcahy H, Murphy TM. DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis. J Crohns Colitis 2016;10:77-86. [PMID: 26419460 DOI: 10.1093/ecco-jcc/jjv176] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
138 Haag LM, Siegmund B. Intestinal microbiota and the innate immune system - A crosstalk in crohn's disease pathogenesis. Front Immunol. 2015;6:489. [PMID: 26441993 DOI: 10.3389/fimmu.2015.00489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
139 Kraiczy J, Nayak K, Ross A, Raine T, Mak TN, Gasparetto M, Cario E, Rakyan V, Heuschkel R, Zilbauer M. Assessing DNA methylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease. Mucosal Immunol. 2016;9:647-658. [PMID: 26376367 DOI: 10.1038/mi.2015.88] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
140 Ferguson LR. Nutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease? Front Immunol 2015;6:467. [PMID: 26441972 DOI: 10.3389/fimmu.2015.00467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
141 El-Matary W, Moroz SP, Bernstein CN. Inflammatory bowel disease in children of Manitoba: 30 years' experience of a tertiary center. J Pediatr Gastroenterol Nutr 2014;59:763-6. [PMID: 25111222 DOI: 10.1097/MPG.0000000000000525] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
142 Smith PJ, Levine AP, Dunne J, Guilhamon P, Turmaine M, Sewell GW, OʼShea NR, Vega R, Paterson JC, Oukrif D. Mucosal Transcriptomics Implicates Under Expression of BRINP3 in the Pathogenesis of Ulcerative Colitis. Inflamm Bowel Dis. 2014;20:1802-1812. [PMID: 25171508 DOI: 10.1097/MIB.0000000000000169] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
143 Adams AT, Kennedy NA, Hansen R, Ventham NT, O’Leary KR, Drummond HE, Noble CL, El-Omar E, Russell RK, Wilson DC. Two-stage genome-wide methylation profiling in childhood-onset Crohn’s Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis. 2014;20:1784-1793. [PMID: 25144570 DOI: 10.1097/mib.0000000000000179] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 7.6] [Reference Citation Analysis]
144 Däbritz J, Menheniott TR. Linking immunity, epigenetics, and cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1638-1654. [PMID: 24896241 DOI: 10.1097/mib.0000000000000063] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
145 Jiang W, Li X. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Mol Diagn Ther 2015;19:141-58. [DOI: 10.1007/s40291-015-0142-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
146 Ho G, Boyapati R, Satsangi J. Ulcerative colitis. Medicine 2015;43:276-81. [DOI: 10.1016/j.mpmed.2015.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
147 Boyapati R, Satsangi J, Ho GT. Pathogenesis of Crohn's disease. F1000Prime Rep. 2015;7:44. [PMID: 26097717 DOI: 10.12703/p7-44] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
148 Kalla R, Ventham NT, Kennedy NA, Quintana JF, Nimmo ER, Buck AH, Satsangi J. MicroRNAs: new players in IBD. Gut 2015;64:504-17. [PMID: 25475103 DOI: 10.1136/gutjnl-2014-307891] [Cited by in Crossref: 165] [Cited by in F6Publishing: 159] [Article Influence: 23.6] [Reference Citation Analysis]
149 Polytarchou C, Koukos G, Iliopoulos D. Systems biology in inflammatory bowel diseases: ready for prime time. Curr Opin Gastroenterol 2014;30:339-46. [PMID: 24837229 DOI: 10.1097/MOG.0000000000000081] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
150 Marjoram L, Alvers A, Deerhake ME, Bagwell J, Mankiewicz J, Cocchiaro JL, Beerman RW, Willer J, Sumigray KD, Katsanis N, Tobin DM, Rawls JF, Goll MG, Bagnat M. Epigenetic control of intestinal barrier function and inflammation in zebrafish. Proc Natl Acad Sci U S A 2015;112:2770-5. [PMID: 25730872 DOI: 10.1073/pnas.1424089112] [Cited by in Crossref: 112] [Cited by in F6Publishing: 100] [Article Influence: 16.0] [Reference Citation Analysis]
151 Brugman S, Perdijk O, van Neerven RJ, Savelkoul HF. Mucosal Immune Development in Early Life: Setting the Stage. Arch Immunol Ther Exp (Warsz) 2015;63:251-68. [PMID: 25666708 DOI: 10.1007/s00005-015-0329-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
152 Tontini GE, Vecchi M, Pastorelli L, Neurath MF, Neumann H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J Gastroenterol 2015; 21(1): 21-46 [PMID: 25574078 DOI: 10.3748/wjg.v21.i1.21] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 91] [Article Influence: 15.6] [Reference Citation Analysis]
153 Gonneaud A, Gagné JM, Turgeon N, Asselin C. The histone deacetylase Hdac1 regulates inflammatory signalling in intestinal epithelial cells. J Inflamm (Lond) 2014;11:43. [PMID: 25606026 DOI: 10.1186/s12950-014-0043-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
154 Ventham NT, Kalla R, Kennedy NA, Satsangi J, Arnott ID. Predicting outcomes in acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2015;9:405-415. [PMID: 25494666 DOI: 10.1586/17474124.2015.992880] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
155 Vargas-martínez F, Uvnäs-moberg K, Petersson M, Olausson HA, Jiménez-estrada I. Neuropeptides as neuroprotective agents: Oxytocin a forefront developmental player in the mammalian brain. Progress in Neurobiology 2014;123:37-78. [DOI: 10.1016/j.pneurobio.2014.10.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
156 Felice C, Lewis A, Armuzzi A, Lindsay JO, Silver A. Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases. Aliment Pharmacol Ther 2015;41:26-38. [PMID: 25367825 DOI: 10.1111/apt.13008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
157 Horjus Talabur Horje CS, Middendorp S, van Koolwijk E, Roovers L, Groenen MJM, Wahab PJ, van Lochem EG. Naive T Cells in the Gut of Newly Diagnosed, Untreated Adult Patients with Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2014;20:1902-9. [DOI: 10.1097/mib.0000000000000203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
158 Latella G, Rogler G, Bamias G, Breynaert C, Florholmen J, Pellino G, Reif S, Speca S, Lawrance IC. Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD. Journal of Crohn's and Colitis 2014;8:1147-65. [DOI: 10.1016/j.crohns.2014.03.008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 12.6] [Reference Citation Analysis]
159 Herzog D, Buehr P, Koller R, Rueger V, Heyland K, Nydegger A, Spalinger J, Schibli S, Braegger CP; Swiss IBD Cohort Study Group. Gender differences in paediatric patients of the swiss inflammatory bowel disease cohort study. Pediatr Gastroenterol Hepatol Nutr 2014;17:147-54. [PMID: 25349830 DOI: 10.5223/pghn.2014.17.3.147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
160 Leone VA, Cham CM, Chang EB. Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases? Curr Opin Immunol 2014;31:16-23. [PMID: 25214301 DOI: 10.1016/j.coi.2014.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
161 Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc. 2014;89:1553-1563. [PMID: 25199861 DOI: 10.1016/j.mayocp.2014.07.002] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 15.9] [Reference Citation Analysis]
162 Jones-Hall YL, Grisham MB. Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease. Pathophysiology. 2014;21:267-288. [PMID: 24935242 DOI: 10.1016/j.pathophys.2014.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
163 Foersch S, Neurath MF. Colitis-associated neoplasia: molecular basis and clinical translation. Cell Mol Life Sci. 2014;71:3523-3535. [PMID: 24830703 DOI: 10.1007/s00018-014-1636-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
164 Hofmanová J, Straková N, Vaculová AH, Tylichová Z, Safaříková B, Skender B, Kozubík A. Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer. Mediators Inflamm 2014;2014:848632. [PMID: 24876678 DOI: 10.1155/2014/848632] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
165 Aguilera M, Darby T, Melgar S. The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models. Cytokine Growth Factor Rev. 2014;25:715-730. [PMID: 24803013 DOI: 10.1016/j.cytogfr.2014.04.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
166 Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol. 2014;11:372-385. [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 12.3] [Reference Citation Analysis]
167 Turgeon N, Gagné JM, Blais M, Gendron FP, Boudreau F, Asselin C. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2014;306:G594-605. [PMID: 24525021 DOI: 10.1152/ajpgi.00393.2013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
168 Freeman HJ. Natural history and long-term clinical course of Crohn’s disease. World J Gastroenterol 2014; 20(1): 31-36 [PMID: 24415855 DOI: 10.3748/wjg.v20.i1.31] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 73] [Article Influence: 10.3] [Reference Citation Analysis]
169 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914-928. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 147] [Cited by in F6Publishing: 143] [Article Influence: 16.3] [Reference Citation Analysis]
170 Koboziev I, Reinoso Webb C, Furr KL, Grisham MB. Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med. 2014;68:122-133. [PMID: 24275541 DOI: 10.1016/j.freeradbiomed.2013.11.008] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 10.6] [Reference Citation Analysis]
171 Rogler G, Vavricka S, Schoepfer A, Lakatos PL. Mucosal healing and deep remission: What does it mean? World J Gastroenterol 2013; 19(43): 7552-7560 [PMID: 24282345 DOI: 10.3748/wjg.v19.i43.7552] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
172 Principi M, Giorgio F, Losurdo G, Neve V, Contaldo A, Di Leo A, Ierardi E. Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? World J Gastrointest Pathophysiol 2013; 4(4): 100-107 [PMID: 24244878 DOI: 10.4291/wjgp.v4.i4.100] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
173 Foster A, Jacobson K. Changing incidence of inflammatory bowel disease: environmental influences and lessons learnt from the South asian population. Front Pediatr. 2013;1:34. [PMID: 24400280 DOI: 10.3389/fped.2013.00034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
174 Mullane K, Winquist RJ, Williams M. Translational paradigms in pharmacology and drug discovery. Biochem Pharmacol 2014;87:189-210. [PMID: 24184503 DOI: 10.1016/j.bcp.2013.10.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
175 Arimura Y, Isshiki H, Onodera K, Nagaishi K, Yamashita K, Sonoda T, Matsumoto T, Takahashi A, Takazoe M, Yamazaki K, Kubo M, Fujimiya M, Imai K, Shinomura Y. Characteristics of Japanese inflammatory bowel disease susceptibility loci. J Gastroenterol 2014;49:1217-30. [PMID: 23942620 DOI: 10.1007/s00535-013-0866-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]